These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25006794)

  • 1. Planning combined treatments of external beam radiation therapy and molecular radiotherapy.
    Cremonesi M; Ferrari M; Botta F; Guerriero F; Garibaldi C; Bodei L; De Cicco C; Grana CM; Pedroli G; Orecchia R
    Cancer Biother Radiopharm; 2014 Aug; 29(6):227-37. PubMed ID: 25006794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology for biologically-based treatment planning for combined low-dose-rate (permanent implant) and high-dose-rate (fractionated) treatment of prostate cancer.
    Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Ben-Porat L; Happersett L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):702-13. PubMed ID: 15708248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
    Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological effect based treatment plan optimization with the linear quadratic model.
    Schell S; Wilkens JJ; Oelfke U
    Z Med Phys; 2010; 20(3):188-96. PubMed ID: 20832006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
    Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise.
    Cicone F; Sjögreen Gleisner K; Sarnelli A; Indovina L; Gear J; Gnesin S; Kraeber-Bodéré F; Bischof Delaloye A; Valentini V; Cremonesi M
    Phys Med; 2024 Jan; 117():103188. PubMed ID: 38042710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning for molecular targeted radionuclide therapy.
    Siantar CH; Vetter K; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):267-80. PubMed ID: 12136519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue.
    Bräuer-Krisch E; Serduc R; Siegbahn EA; Le Duc G; Prezado Y; Bravin A; Blattmann H; Laissue JA
    Mutat Res; 2010; 704(1-3):160-6. PubMed ID: 20034592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose.
    Li XA; Wang JZ; Stewart RD; Dibiase SJ; Wang D; Lawton CA
    Br J Radiol; 2008 Jan; 81(961):59-68. PubMed ID: 18039721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment modalities in radiation therapy.
    Holland J
    J Intraven Nurs; 2001; 24(2):95-101. PubMed ID: 11836839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The normal tissue effects of microbeam radiotherapy: What do we know, and what do we need to know to plan a human clinical trial?
    Smyth LM; Senthi S; Crosbie JC; Rogers PA
    Int J Radiat Biol; 2016 Jun; 92(6):302-11. PubMed ID: 26982077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we need fractionation-corrected doses in sequential two-phase treatments? A quantification of dose differences between non-corrected and corrected combined non-uniform dose distributions in normal tissue.
    Olsson C; Johansson KA
    Acta Oncol; 2010 Nov; 49(8):1253-60. PubMed ID: 20586660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of radiobiological concepts in radionuclide therapy of cancer.
    Kumar C; Shetake N; Desai S; Kumar A; Samuel G; Pandey BN
    Int J Radiat Biol; 2016; 92(4):173-86. PubMed ID: 26917443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of external beam in brachytherapy.
    Zaider M; Zelefsky MJ; Cohen GN; Chui CS; Yorke ED; Hunt MA; Happersett L
    Future Oncol; 2007 Apr; 3(2):159-68. PubMed ID: 17381416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
    Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
    Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.